Status:
COMPLETED
Efficacy of Ipomea Pes-caprae Ointment as an add-on Therapy in Patient With Jellyfish Dermatitis
Lead Sponsor:
Mahidol University
Conditions:
Jellyfish Dermatitis
Jellyfish Venoms
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is an open label, prospective, test of superiority efficacy trial of Ipomea pes-caprae ointment as an add-on therapy in patient with jellyfish dermatitis. Each patient will receive standard medic...
Detailed Description
The "Test area" and "Control area" are allocated in each participant. We use the Internal Control fashion. The healing time of each area will be collected as an outcome measure.
Eligibility Criteria
Inclusion
- clinical diagnosis of jellyfish dermatitis
- total lesion area is more than 4 square centimeter
Exclusion
- expose to jellyfish more than 7 days
- severe systemic reaction to jellyfish
- allergy to Ipomea pes-caprae or the component of the ointments
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2017
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT00944203
Start Date
July 1 2009
End Date
March 1 2017
Last Update
March 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University
Bangkok, Thailand, 10400